Literature DB >> 21940529

Complications after 1000 lung radiofrequency ablation sessions in 420 patients: a single center's experiences.

Masataka Kashima1, Koichiro Yamakado, Haruyuki Takaki, Hiroshi Kodama, Tomomi Yamada, Junji Uraki, Atsuhiro Nakatsuka.   

Abstract

OBJECTIVE: This study retrospectively evaluates complications after lung radiofrequency ablation (RFA).
MATERIALS AND METHODS: Complications were assessed for each RFA session in 420 consecutive patients with 1403 lung tumors who underwent 1000 RFA sessions with a cool-tip RFA system. A major complication was defined as a grade 3 or 4 adverse event. Risk factors affecting frequent major complications that occurred with an incidence of 1% or more were detected using multivariate analysis.
RESULTS: Four deaths (0.4% [4/1000]) related to RFA procedures occurred. Three patients died of interstitial pneumonia. The other patient died of hemothorax. The major complication rate was 9.8% (98/1000). Frequent major complications were aseptic pleuritis (2.3% [23/1000]), pneumonia (1.8% [18/1000]), lung abscess (1.6% [16/1000]), bleeding requiring blood transfusion (1.6% [16/1000]), pneumothorax requiring pleural sclerosis (1.6% [16/1000]), followed by bronchopleural fistula (0.4% [4/1000]), brachial nerve injury (0.3% [3/1000]), tumor seeding (0.1% [1/1000]), and diaphragm injury (0.1% [1/1000]). Puncture number (p < 0.02) and previous systemic chemotherapy (p < 0.05) were significant risk factors for aseptic pleuritis. Previous external beam radiotherapy (p < 0.001) and age (p < 0.02) were significant risk factors for pneumonia, as were emphysema (p < 0.02) for lung abscess, and serum platelet count (p < 0.002) and tumor size (p < 0.02) for bleeding. Emphysema (p < 0.02) was a significant risk factor for pneumothorax requiring pleural sclerosis.
CONCLUSION: Lung RFA is a relatively safe procedure, but it can be fatal. Risk factors found in this study will help to stratify high-risk patients.

Entities:  

Mesh:

Year:  2011        PMID: 21940529     DOI: 10.2214/AJR.11.6408

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  56 in total

Review 1.  Percutaneous ablation of colorectal lung metastases.

Authors:  Carole A Ridge; Stephen B Solomon
Journal:  J Gastrointest Oncol       Date:  2015-12

Review 2.  Lung radiofrequency and microwave ablation: a review of indications, techniques and post-procedural imaging appearances.

Authors:  S L Smith; P E Jennings
Journal:  Br J Radiol       Date:  2014-12-03       Impact factor: 3.039

Review 3.  Expert consensus on image-guided radiofrequency ablation of pulmonary tumors-2015 edition.

Authors:  Bao-Dong Liu; Xiu-Yi Zhi
Journal:  J Thorac Dis       Date:  2015-05       Impact factor: 2.895

Review 4.  Prevention and management of infectious complications of percutaneous interventions.

Authors:  Steven Y Huang; Asher Philip; Michael D Richter; Sanjay Gupta; Mark L Lessne; Charles Y Kim
Journal:  Semin Intervent Radiol       Date:  2015-06       Impact factor: 1.513

Review 5.  Common complications of nonvascular percutaneous thoracic interventions: diagnosis and management.

Authors:  Azzam Khankan; Shireen Sirhan; Fadi Aris
Journal:  Semin Intervent Radiol       Date:  2015-06       Impact factor: 1.513

Review 6.  Expert consensus on image-guided radiofrequency ablation of pulmonary tumors-2015 edition.

Authors:  Bao-Dong Liu; Xiu-Yi Zhi
Journal:  Ann Transl Med       Date:  2015-06

Review 7.  Expert consensus on image-guided radiofrequency ablation of pulmonary tumors-2015 edition.

Authors:  Bao-Dong Liu; Xiu-Yi Zhi
Journal:  Transl Lung Cancer Res       Date:  2015-06

Review 8.  Lung Ablation: Indications and Techniques.

Authors:  Bashir Akhavan Tafti; Scott Genshaft; Robert Suh; Fereidoun Abtin
Journal:  Semin Intervent Radiol       Date:  2019-08-19       Impact factor: 1.513

9.  Pleural puncture that excludes the ablation zone decreases the risk of pneumothorax after percutaneous microwave ablation in porcine lung.

Authors:  Kyungmouk Steve Lee; Haruyuki Takaki; Hooman Yarmohammadi; Govindarajan Srimathveeravalli; Kerith Luchins; Sébastien Monette; Sreejit Nair; Sirish Kishore; Joseph P Erinjeri
Journal:  J Vasc Interv Radiol       Date:  2015-03-05       Impact factor: 3.464

Review 10.  Lung cancer ablation: what is the evidence?

Authors:  Thierry de Baere; Geoffroy Farouil; Frederic Deschamps
Journal:  Semin Intervent Radiol       Date:  2013-06       Impact factor: 1.513

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.